CLINICAL_TRIALS
trial_result
· 2021-03-12
Clinical Trial Update: GliflOzin in eLderly Diabetic patiENts: A praGmatic Intraclass Evaluation Trial [Phase 4]
Summary
A Phase 4 pragmatic intraclass evaluation trial of GliflOzin in elderly patients with Type 2 diabetes is ongoing, with uncertain status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Center for Outcomes Research and Clinical Epidemiology, Italy | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: UNKNOWN